Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Georges

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Molecular Biosciences|February 14, 2022
Comparing Antibody Interfaces to Inform Rational Design of New Antibody FormatsMonica L Fernández-Quintero, Patrick K Quoika, Florian S Wedl, et al.
Frontiers in Molecular Biosciences|March 4, 2022
Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody FormatsMonica L Fernández-Quintero, Patrick K Quoika, Florian S Wedl, et al.
Mabs|April 28, 2026
Engineering of acidic pH-responsive anti-CD3 binding antibodiesGrégory La Sala, Katharina B Kroell, Mudita Pincha, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodiesWolfgang Schaefer, Jörg T Regula, Monika Bähner, et al.
Biological Chemistry|January 24, 2022
Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodiesSteffen Dickopf, Can Buldun, Vedran Vasic, et al.
African Journal of Infectious Diseases|March 3, 2015
Investigation of an outbreak of acute respiratory disease in côte d'ivoire in april 2007Euloge Ekaza, Hervé Adjé Kadjo, Daouda Coulibaly, et al.
The Biochemical Journal|December 3, 2011
Allosteric antibody inhibition of human hepsin proteaseTobias Koschubs, Stefan Dengl, Harald Dürr, et al.
Journal of Medicinal Chemistry|December 7, 2010
Phthalazinone pyrazoles as potent, selective, and orally bioavailable inhibitors of Aurora-A kinaseMichael E Prime, Stephen M Courtney, Frederick A Brookfield, et al.
Mabs|February 23, 2023
Assessing developability early in the discovery process for novel biologicsMonica L Fernández-Quintero, Anne Ljungars, Franz Waibl, et al.
Nucleic Acids Research|October 30, 2025
Improved targeted delivery of antisense oligonucleotide with an antibody maskHung-En Hsia, Chiara Zanini, Claire Simonneau, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Molecular Biosciences|February 14, 2022
Comparing Antibody Interfaces to Inform Rational Design of New Antibody FormatsMonica L Fernández-Quintero, Patrick K Quoika, Florian S Wedl, et al.
Frontiers in Molecular Biosciences|March 4, 2022
Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody FormatsMonica L Fernández-Quintero, Patrick K Quoika, Florian S Wedl, et al.
Mabs|April 28, 2026
Engineering of acidic pH-responsive anti-CD3 binding antibodiesGrégory La Sala, Katharina B Kroell, Mudita Pincha, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodiesWolfgang Schaefer, Jörg T Regula, Monika Bähner, et al.
Biological Chemistry|January 24, 2022
Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodiesSteffen Dickopf, Can Buldun, Vedran Vasic, et al.
African Journal of Infectious Diseases|March 3, 2015
Investigation of an outbreak of acute respiratory disease in côte d'ivoire in april 2007Euloge Ekaza, Hervé Adjé Kadjo, Daouda Coulibaly, et al.
The Biochemical Journal|December 3, 2011
Allosteric antibody inhibition of human hepsin proteaseTobias Koschubs, Stefan Dengl, Harald Dürr, et al.
Journal of Medicinal Chemistry|December 7, 2010
Phthalazinone pyrazoles as potent, selective, and orally bioavailable inhibitors of Aurora-A kinaseMichael E Prime, Stephen M Courtney, Frederick A Brookfield, et al.
Mabs|February 23, 2023
Assessing developability early in the discovery process for novel biologicsMonica L Fernández-Quintero, Anne Ljungars, Franz Waibl, et al.
Nucleic Acids Research|October 30, 2025
Improved targeted delivery of antisense oligonucleotide with an antibody maskHung-En Hsia, Chiara Zanini, Claire Simonneau, et al.
Pageof 7